People living with HIV and those potentially exposed to HIV in China are expected to benefit from GlaxoSmithKline's (GSK) innovative research to prevent and treat the disease, as the global pharmaceutical company seeks to further expand its presence in the market.
“GSK’s innovative and cost-effective HIV treatment and prevention solutions in China will contribute to overall improvements in AIDS prevention and care in the country ,” said Lauren Carey, vice president and head of the international region for ViiV Healthcare, GSK’s HIV care subsidiary.
Carey's announcement comes after the London-based company announced in May that its innovative drug PrEP, or pre-exposure prophylaxis, which reduces the chance of HIV transmission, had been approved for the Chinese market, with the long-acting option able to last for two months for people at risk.
“Our scientists continue to bring new innovations to people living with HIV in China. In doing so, we base our innovations on the needs and wishes of patients, as well as on the opinions of clinicians ,” said Carey.
Read more CHINA NEWS Chinese FDI in Europe
GSK launches innovative HIV prevention and treatment programs in China
This month, GSK also launched the second phase of an HIV awareness and education project with the China Association for the Prevention and Control of STDs and AIDS, aimed at improving public understanding of HIV and reducing discrimination in society.
“Going forward, we will also step up our efforts to improve access to HIV medicines in China. This includes our participation in the national reimbursement list, with the aim of easing the economic burden on these patients in the long term ,” said Tim Zhang, vice president and head of GSK’s specialty medicines business in China.
According to the report on the mortality and prevalence trends of reported HIV/AIDS cases in China released by the Chinese Center for Disease Control and Prevention, there will be 1.223 million HIV/AIDS cases barbados email address registered nationwide by the end of 2022, with 107,000 new cases reported in 2022, an obvious downward trend.
Read more CHINA NEWS New policies to boost China's economic growth
"China's HIV prevention efforts have achieved remarkable results so far. More and more HIV-infected people are receiving routine testing and systematic treatment, turning what was once a fatal disease into a manageable chronic infectious disease ," said Dai Lili, a professor at Beijing Yuan Hospital affiliated with Capital Medical University.
But HIV prevention still faces significant challenges, including the continued expansion of high-burden areas, rising numbers of new cases among adolescents and older people, increasing late detection and severe comorbidities, Dai said. " The road to HIV prevention and treatment is long and arduous ."
China News “GSK: Fight against HIV in China – New Hope for Millions” was prepared by PRC.TODAY Portal based on materials from the China Daily website.
- Board index
- All times are UTC
- Delete cookies
- Contact us